Biotoxtech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	52,743	44,254	52,429	98,113	119,140	117,384
Market Cap Growth	16.49%	-15.59%	-46.56%	-17.65%	1.50%	-47.09%
Enterprise Value	78,885	75,280	78,212	127,342	128,169	118,446
Last Close Price	3355.00	2815.00	3335.00	6160.00	8140.00	8020.00
PE Ratio	45.34	38.06	-	-	43.72	16.50
PS Ratio	1.12	0.94	1.27	3.01	3.20	3.59
PB Ratio	1.65	1.39	1.52	2.03	2.69	2.81
P/TBV Ratio	1.36	1.14	1.37	1.96	2.79	2.96
P/FCF Ratio	11.68	9.80	-	-	-	-
P/OCF Ratio	7.95	6.67	-	-	-	27.01
EV/Sales Ratio	1.68	1.60	1.89	3.90	3.44	3.62
EV/EBITDA Ratio	-	-	-	-	46.70	18.79
EV/EBIT Ratio	-	-	-	-	160.20	25.57
EV/FCF Ratio	17.47	16.67	-	-	-	-
Debt / Equity Ratio	1.96	1.96	1.83	1.28	1.11	0.65
Debt / EBITDA Ratio	-	-	-	-	17.90	4.29
Debt / FCF Ratio	13.84	13.84	-	-	-	-
Net Debt / Equity Ratio	1.08	1.08	0.89	0.43	0.41	-0.03
Net Debt / EBITDA Ratio	-21.81	-21.81	-6.78	-4.11	6.69	-0.17
Net Debt / FCF Ratio	7.61	7.61	-3.37	-0.99	-0.57	0.34
Asset Turnover	0.35	0.35	0.29	0.24	0.35	0.42
Inventory Turnover	3.75	3.75	2.91	3.76	9.70	29.42
Quick Ratio	0.44	0.44	0.50	0.62	0.64	0.77
Current Ratio	0.57	0.57	0.72	0.86	0.83	0.83
Return on Equity (ROE)	-4.74%	-4.74%	-30.59%	-19.33%	0.15%	17.59%
Return on Assets (ROA)	-2.76%	-2.76%	-3.80%	-3.98%	0.46%	3.75%
Return on Invested Capital (ROIC)	-8.47%	-8.99%	-12.87%	-13.19%	1.55%	13.03%
Return on Capital Employed (ROCE)	-12.80%	-12.80%	-16.00%	-12.10%	1.20%	10.30%
Earnings Yield	2.20%	2.63%	-12.26%	-4.97%	2.29%	6.06%
FCF Yield	8.56%	10.20%	-17.35%	-21.09%	-26.85%	-2.79%
Buyback Yield / Dilution	0.99%	0.99%	-2.86%	-5.42%	4.91%	-5.41%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.